CD44, a well-known cancer stem cell (CSC) biomarker [9], is expressed on leukocyte [10] and tumor cells [11] and involved crucially in inflammatory leukocyte homing, tumorigenesis and cancer progression [12,13]. The gene discussed is CD44; the disease is neoplasm.